DPP4 and diabetic foot: Animal experiments and clinical studies have indicated that DPP‐4 inhibitors can increase circulating levels of EPCs [14, 15, 16] and potentially facilitate the healing of diabetic foot ulcers (DFUs) [17, 18]; however, these findings remain preliminary and are subject to debate [19].